Brian Keegan

Oct 28, 2024 | boulderweekly.com | Brian Keegan

The Penfield Tate II Municipal Building, where Boulder's city council meets. Courtesy: City of Boulder Whether through the genius of federalism or the gridlock of a do-nothing Congress, the decisions of local politicians have far greater impact on most residents’ lives than national offices. But local politicians face unusual expectations that their professional work should not be professionally compensated.

Aug 7, 2024 | dailycamera.com | Brian Keegan

By Brian C. KeeganSteve Pomerance’s July 26 column invited a “serious discussion about alternative paths” to stop population growth in Colorado. Population control, exorcised decades ago from mainstream demography and environmentalism, is being reanimated in an age of climate anxiety. When pressed for solutions instead of grievances, alarmists might disavow the forced sterilizations and one-child policies that were the shameful consequences of similar mid-century population anxieties.

Aug 6, 2024 | ajmc.com | Brian Keegan |Giselle Mosnaim |Stanley Goldstein |Anitha Shrikhande

OpinionVideoAugust 6, 2024Author(s):,Panelists discuss how 30%-50% of patients with chronic spontaneous urticaria remain symptomatic despite treatment, examining the impact of treatment burdens, the limitations of targeting the IgE pathway, and the need for new therapies addressing the IgG pathway. Video content above is prompted by the following:A significant percentage (30%-50%) of patients are still symptomatic with chronic spontaneous urticaria while on certain recommended doses.

Aug 6, 2024 | ajmc.com | Brian Keegan |Giselle Mosnaim |Stanley Goldstein |Anitha Shrikhande

Aug 6, 2024 | ajmc.com | Brian Keegan |Giselle Mosnaim |Stanley Goldstein |Anitha Shrikhande

OpinionVideoAugust 6, 2024Author(s):A panel of experts discuss the positives and negatives in using omalizumab when treating patients with CSU. Video content above is prompted by the following:A significant percentage (30%-50%) of patients are still symptomatic with chronic spontaneous urticaria while on recommended doses of omalizumab. What do you believe accounts for this high number of patients who are not responding adequately? Patients have to come in for first 3 doses because this a biologic.